Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty
Open Access
- 1 August 2015
- Vol. 33 (36) , 4565-4571
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adultsVaccine, 2011
- Influenza vaccine responses in older adultsAgeing Research Reviews, 2011
- Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and OlderThe Journal of Infectious Diseases, 2009
- From bench to bedside and back: the SENIEUR Protocol and the efficacy of influenza vaccination in the elderlyBiogerontology, 2008
- Influenza vaccine effectiveness among 50–64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003–2004Vaccine, 2007
- Impact of Influenza Vaccination on Seasonal Mortality in the US Elderly PopulationArchives of internal medicine (1960), 2005
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004
- Clinical and serological responses to an inactivated influenza vaccine in adults with HIV infection, diabetes, obstructive airways disease, elderly adults and healthy volunteersInternational Journal of STD & AIDS, 1997
- Statistics in Epidemiology: The Case-Control StudyJournal of the American Statistical Association, 1996
- The Immunogenicity of Influenza Virus Vaccine in Solid Organ Transplant RecipientsClinical Infectious Diseases, 1996